← Back to Research Articles

Multi-domain Online Therapeutic Investigation Of Neurocognition (MOTION) – A randomized comparative-effectiveness study of two remotely delivered mind-body interventions for older adults with cognitive decline

Authors: Chao, L. L. and Barnes, D. E. and Chesney, M. A. and Mehling, W. E. and Lee, J. A. and Benjamin, C. and Lavretsky, H. and Ercoli, L. and Siddarth, P. and Narr, K. L.

Year: 2025 Journal: Contemp Clin Trials Vol/Issue: Vol. 149 Pages: 107811

Study Characteristics

Lifestyle Pillars
ConnectednessPhysical ActivityStress Management
Study Design
RCT

Abstract

Background

Research suggest that mind-body movement programs have beneficial effects on cognitive outcomes for older adults with cognitive decline. However, few studies have directly compared specific approaches to mind-body movement or studied the impact of remote program delivery.

Methods

In a 3-arm randomized controlled trial (RCT) for older adults with cognitive impairment, we are comparing a multidomain mind-body program that emphasizes movement, body awareness, personal meaningfulness, and social connection, and a traditional Chinese mind-body exercise (Tai Chi) to a health and wellness education control condition. All 3 interventions are delivered remotely two times per week (onehour per session) for 12 weeks. The two active interventions are live-streamed. Outcomes are assessed prior to, after, and 6-months after the interventions. The co-primary outcomes are changes on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog) and brain functional connectivity in the Default Mode Network (DMN). Secondary outcomes include measures of specific cognitive domains (e.g., executive function, attention), mobility, and self-report measures of general well-being, quality of life, social engagement, self- and attention-regulation.

Conclusion

This RCT will directly compare the effects of two mind-body movement programs versus an education control delivered remotely over 12 weeks on cognitive, neuroimaging, and participant-reported outcomes. If successful, these programs may provide scalable strategies for slowing cognitive decline, which could potentially delay dementia onset in some individuals.

Trial Registration Id

NCT05217849.